Peripheral artery disease: How do genes and pharmacology interplay?
- PMID: 29894588
- DOI: 10.1002/ccd.27649
Peripheral artery disease: How do genes and pharmacology interplay?
Abstract
In patients with peripheral artery disease, high on-treatment platelet reactivity (HoTPR) might be associated with worse outcomes for those taking clopidogrel, but not for those taking aspirin. Certain genetic polymorphisms might account for HoTPR. Current literature supports the importance of antiplatelet therapy in treating patients with PAD with clopidogrel, aspirin, or both.
© 2018 Wiley Periodicals, Inc.
Comment on
-
Aspirin and clopidogrel high on-treatment platelet reactivity and genetic predictors in peripheral arterial disease.Catheter Cardiovasc Interv. 2018 Jun;91(7):1308-1317. doi: 10.1002/ccd.27453. Epub 2018 Feb 7. Catheter Cardiovasc Interv. 2018. PMID: 29411531 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
